4
Changes in Ownership
RESMED INC Filed Acc 0001127602-24-018325
Chief Executive Officer sold 14,683 shares at $211.66 ($3,107,739)
- Chief Executive Officer acquired 14,683 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Farrell Michael J. Chief Executive Officer | 2024-06-07 | Option exercise 10b5-1 | +14,683 | $84.98 | $1,247,761 | 455,482 | D: show line 1 in the form |
| Farrell Michael J. Chief Executive Officer | 2024-06-07 | Sale 10b5-1 | −14,683 | $211.66 | $3,107,739 | 440,799 | D: show line 2 in the form |
| Open-market sales · 14,683 sh · avg $211.66 · $3,107,739 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Farrell Michael J. Chief Executive Officer | 2024-06-07 | Option exercise · ResMed Common Stock Options 10b5-1 | −14,683 | 73,415 | D: show line 3 in the form |
Loading xslF345X05/form4.xml…